Form 8-K - Current report:
SEC Accession No. 0001437749-20-009269
Filing Date
2020-05-04
Accepted
2020-05-04 16:30:40
Documents
6
Period of Report
2020-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200504_8k.htm 8-K 21319
2 EXHIBIT 99.1 ex_184427.htm EX-99.1 50302
3 newpipeline800.jpg GRAPHIC 123266
4 onein10americanscopy.jpg GRAPHIC 41277
5 sl-1.jpg GRAPHIC 34264
6 sl-3.jpg GRAPHIC 34890
  Complete submission text file 0001437749-20-009269.txt   393758
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20845276
SIC: 2834 Pharmaceutical Preparations